VITA 34 AG (VTIAF)
USD 5.99
(0.0%)
USD 5.99
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.39 Million EUR | 129.12% |
| 2022 | -18.47 Million EUR | -1791.8% |
| 2021 | 791 Thousand EUR | -82.2% |
| 2020 | 5 Million EUR | -6.81% |
| 2019 | 5.31 Million EUR | 22.77% |
| 2018 | 4.73 Million EUR | 184.5% |
| 2017 | 1.84 Million EUR | -26.89% |
| 2016 | 2.2 Million EUR | -42.07% |
| 2015 | 136 Thousand EUR | 52.64% |
| 2014 | 2.53 Million EUR | -3.63% |
| 2013 | 2.65 Million EUR | 494.88% |
| 2012 | 414 Thousand EUR | -38.83% |
| 2011 | 638 Thousand EUR | -61.27% |
| 2010 | 1.89 Million EUR | 35.36% |
| 2009 | 1.4 Million EUR | 203.17% |
| 2008 | -1.35 Million EUR | -1300.88% |
| 2007 | 113 Thousand EUR | -98.76% |
| 2006 | 988 Thousand EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 674 Thousand EUR | 70.48% |
| 2024 Q1 | 1.19 Million EUR | 0.0% |
| 2023 Q2 | 1.6 Million EUR | 135.64% |
| 2023 Q3 | 2.96 Million EUR | 85.13% |
| 2023 Q1 | 679 Thousand EUR | 103.9% |
| 2023 FY | - EUR | 129.12% |
| 2023 Q4 | 1.43 Million EUR | -51.62% |
| 2022 Q4 | -17.41 Million EUR | -1064.54% |
| 2022 FY | - EUR | -1791.8% |
| 2022 Q2 | -1.15 Million EUR | -24.49% |
| 2022 Q1 | -931 Thousand EUR | 65.87% |
| 2022 Q3 | 1.8 Million EUR | 255.74% |
| 2021 FY | - EUR | -82.2% |
| 2021 Q1 | 1.06 Million EUR | 7.71% |
| 2021 Q3 | 1.67 Million EUR | 72.18% |
| 2021 Q2 | 974 Thousand EUR | -8.29% |
| 2021 Q4 | -2.72 Million EUR | -262.67% |
| 2020 FY | - EUR | -6.81% |
| 2020 Q4 | 986 Thousand EUR | -44.42% |
| 2020 Q2 | 1.48 Million EUR | 27.09% |
| 2020 Q1 | 1.17 Million EUR | -3.7% |
| 2020 Q3 | 1.77 Million EUR | 19.3% |
| 2019 FY | - EUR | 22.77% |
| 2019 Q3 | 1.76 Million EUR | 15.79% |
| 2019 Q1 | 1.29 Million EUR | 68.75% |
| 2019 Q2 | 1.52 Million EUR | 17.28% |
| 2019 Q4 | 1.21 Million EUR | -30.97% |
| 2018 Q1 | 1.07 Million EUR | 11.83% |
| 2018 FY | - EUR | 184.5% |
| 2018 Q2 | 953 Thousand EUR | -11.6% |
| 2018 Q3 | 1.29 Million EUR | 35.36% |
| 2018 Q4 | 768 Thousand EUR | -40.47% |
| 2017 Q3 | 1.08 Million EUR | 200.09% |
| 2017 FY | - EUR | -26.89% |
| 2017 Q4 | 964 Thousand EUR | -10.91% |
| 2017 Q1 | 723 Thousand EUR | 26.84% |
| 2017 Q2 | -1.08 Million EUR | -249.52% |
| 2016 Q1 | 366 Thousand EUR | -82.58% |
| 2016 Q4 | 570 Thousand EUR | -25.29% |
| 2016 Q3 | 763 Thousand EUR | 37.48% |
| 2016 Q2 | 555 Thousand EUR | 51.64% |
| 2016 FY | - EUR | -42.07% |
| 2015 Q4 | 2.1 Million EUR | 231.39% |
| 2015 Q2 | 518 Thousand EUR | -21.52% |
| 2015 FY | - EUR | 52.64% |
| 2015 Q3 | 634 Thousand EUR | 22.39% |
| 2015 Q1 | 660 Thousand EUR | -39.45% |
| 2014 Q3 | 846 Thousand EUR | 255.46% |
| 2014 Q4 | 1.09 Million EUR | 28.84% |
| 2014 Q1 | 638 Thousand EUR | -40.49% |
| 2014 Q2 | 238 Thousand EUR | -62.7% |
| 2014 FY | - EUR | -3.63% |
| 2013 Q4 | 1.07 Million EUR | 67.76% |
| 2013 FY | - EUR | 494.88% |
| 2013 Q2 | 562 Thousand EUR | 41.21% |
| 2013 Q3 | 639 Thousand EUR | 13.7% |
| 2013 Q1 | 398 Thousand EUR | 107.29% |
| 2012 Q4 | 192 Thousand EUR | 16.36% |
| 2012 Q1 | 34 Thousand EUR | -89.34% |
| 2012 Q2 | 58 Thousand EUR | 70.59% |
| 2012 Q3 | 165 Thousand EUR | 184.48% |
| 2012 FY | - EUR | -38.83% |
| 2011 Q4 | 319 Thousand EUR | -36.45% |
| 2011 Q2 | 32 Thousand EUR | 126.89% |
| 2011 Q1 | -119 Thousand EUR | -117.32% |
| 2011 FY | - EUR | -61.27% |
| 2011 Q3 | 502 Thousand EUR | 1468.75% |
| 2010 Q2 | 398 Thousand EUR | 5.85% |
| 2010 Q3 | 434 Thousand EUR | 9.05% |
| 2010 Q1 | 376 Thousand EUR | -8.07% |
| 2010 Q4 | 687 Thousand EUR | 58.29% |
| 2010 FY | - EUR | 35.36% |
| 2009 FY | - EUR | 203.17% |
| 2009 Q1 | -22 Thousand EUR | 0.0% |
| 2009 Q2 | 214 Thousand EUR | 1072.73% |
| 2009 Q4 | 409 Thousand EUR | -35.69% |
| 2009 Q3 | 636 Thousand EUR | 197.2% |
| 2008 Q2 | -784 Thousand EUR | 0.0% |
| 2008 FY | - EUR | -1300.88% |
| 2007 FY | - EUR | -98.76% |
| 2006 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.98 Million USD | 149.074% |
| Arem Pacific Corporation | 36.71 Thousand USD | -14580.648% |
| Assisted 4 Living, Inc. | -112.91 Thousand USD | 4873.671% |
| BioCorRx Inc. | -2.68 Million USD | 300.826% |
| Bionik Laboratories Corp. | -4.77 Million USD | 212.863% |
| Banyan Corp. | 583.94 Thousand USD | -823.037% |
| Clearday, Inc. | -7.53 Million USD | 171.52% |
| Dental Patient Care America, Inc. | 12.87 Thousand USD | -41770.582% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | -1.08 Million USD | 595.277% |
| First Choice Healthcare Solutions, Inc. | -2.2 Million USD | 343.915% |
| Selectis Health, Inc. | -7.29 Million USD | 173.894% |
| Ethema Health Corporation | 2.07 Million USD | -160.114% |
| HealthLynked Corp. | -2.75 Million USD | 295.978% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 303.06% |
| JRSIS Health Care Corporation | 28.84 Thousand USD | -18585.433% |
| Comjoyful International Company | 167.89 Thousand USD | -3110.34% |
| Medical Facilities Corporation | 77.94 Million USD | 93.085% |
| MedSmart Group Inc. | 47.8 Thousand USD | -11174.028% |
| North America Frac Sand, Inc. | -623.33 Thousand USD | 964.711% |
| Nova Leap Health Corp. | 994.46 Thousand USD | -442.0% |
| Nexteligent Holdings, Inc. | -201.73 Thousand USD | 2771.888% |
| PAO Group, Inc. | 292.96 Thousand USD | -1739.823% |
| Primemd Inc. | 3.42 Million USD | -57.283% |
| Raffles Medical Group Ltd | 100.7 Million USD | 94.647% |
| Ryman Healthcare Limited | -54.51 Million USD | 109.887% |
| Stem Cell Authority, Ltd. | -4233.00 USD | 127432.861% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -2.89 Million USD | 286.231% |
| Mycotopia Therapies, Inc. | -555.5 Thousand USD | 1070.285% |
| U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | 11100.0% |
| Veltex Corporation | -938.45 Thousand USD | 674.347% |
| World Financial Holding Group | -28.43 Thousand USD | 19058.846% |
| Xcelerate Inc. | -2.53 Million USD | 312.343% |